Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01737398
Recruitment Status : Completed
First Posted : November 29, 2012
Last Update Posted : June 19, 2018
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.